Impact of apoE genotype on oxidative stress, inflammation and disease risk

Molecular Nutrition & Food Research
Laia Jofre-MonsenyGerald Rimbach

Abstract

Although in developing countries an apolipoprotein E4 (apoE4) genotype may offer an evolutionary advantage, as it has been shown to offer protection against certain infectious disease, in Westernised societies it is associated with increased morbidity and mortality, and represents a significant risk factor for cardiovascular disease, late-onset Alzheimer's disease and other chronic disorders. ApoE is an important modulator of many stages of lipoprotein metabolism and traditionally the increased risk was attributed to higher lipid levels in E4 carriers. However, more recent evidence demonstrates the multifunctional nature of the apoE protein and the fact that the impact of genotype on disease risk may be in large part due to an impact on oxidative status or the immunomodulatory/anti-inflammatory properties of apoE. An increasing number of studies in cell lines, targeted replacement rodents and human volunteers indicate higher oxidative stress and a more pro-inflammatory state associated with the epsilon4 allele. The impact of genotype on the antioxidant and immunomodulatory/anti-inflammatory properties of apoE is the focus of the current review. Furthermore, current information on the impact of environment (diet, exercise, smoki...Continue Reading

References

Jun 1, 1985·Archives of Biochemistry and Biophysics·H J KaydenM G Traber
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S K BasuJ L Goldstein
May 1, 1995·The Annals of Thoracic Surgery·M F NewmanE P Mahanna
Jun 30, 1994·Biochemical and Biophysical Research Communications·T HayekM Aviram
Sep 18, 1993·Lancet·J PoirierS Gauthier
Oct 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·P W WilsonJ M Ordovas
Jun 1, 1997·Journal of Neuroimmunology·D T LaskowitzW D Matthew
Jul 21, 1998·Brain Pathology·R EgenspergerM B Graeber
Sep 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·J StöhrG Schmitz
Feb 3, 2000·Free Radical Biology & Medicine·C JolivaltG Siest
May 20, 2000·Annals of the New York Academy of Sciences·M J LaduG S Getz
Oct 12, 2000·The Journal of Biological Chemistry·R K TangiralaD J Rader
Dec 28, 2000·Acta Neurologica Scandinavica·Y IharaS Kuroda
Jan 3, 2001·European Journal of Pharmacology·S J Peroutka, D M Dreon
Aug 18, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·N DrabeM Turina
Apr 12, 2002·Journal of Neuroscience Research·Kazuo KitagawaMasatsugu Hori
Apr 16, 2002·European Journal of Clinical Investigation·D Gómez-CoronadoM A Lasunción
Jun 5, 2002·Mechanisms of Ageing and Development·ZhongMao GuoRobert Reddick
Jun 22, 2002·Annals of the New York Academy of Sciences·Carola A ColtonMichael P Vitek
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Matthew A WozniakUNKNOWN Trent HCV Study Group

❮ Previous
Next ❯

Citations

Sep 3, 2008·International Journal of Colorectal Disease·Keshen LiDongwei Mao
Nov 17, 2009·Archives of Dermatological Research·Pablo Coto-SeguraJorge Santos-Juanes
Mar 2, 2011·Journal of Neural Transmission·Chikako KiyoharaUNKNOWN Fukuoka Kinki Parkinson’s Disease Study Group
Jun 12, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Hong-Wei LiuYing Wang
Nov 16, 2012·The British Journal of Nutrition·Cheryl S GammonWelma Stonehouse
Feb 28, 2009·The Proceedings of the Nutrition Society·Gerald Rimbach, Anne M Minihane
Feb 1, 2012·Molecular Psychiatry·C L Raison, A H Miller
Aug 4, 2009·Journal of Neurotrauma·Lisa M MoranKeith O Yeates
Oct 22, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Yusuke TakataJunko H Ohyashiki
Jul 21, 2011·Mediators of Inflammation·Hongliang ZhangJiang Wu
Apr 25, 2012·BMC Gastroenterology·Orleâncio Gomes R AzevedoReinaldo B Oriá
Jan 30, 2010·Lipids in Health and Disease·Inga KuhlmannGerald Rimbach
Apr 22, 2009·BMC Medical Genomics·Deanna S CrossCatherine A McCarty
Nov 20, 2008·Journal of Lipid Research·Godfrey S Getz, Catherine A Reardon
Dec 11, 2013·Clinical & Developmental Immunology·Jing-qin NiYun Zhang
Dec 1, 2010·Nutrition Reviews·Greg M ColeSally A Frautschy
Aug 1, 2008·Nutrition Reviews·Jean-Marc ZinggMohsen Meydani
Apr 9, 2009·The Journal of Clinical Endocrinology and Metabolism·Assel BiyashevaMargrit Urbanek
Sep 25, 2012·Current Nutrition Reports·Caren E Smith
Jul 3, 2015·Biogerontology·Irene Maeve ReaUNKNOWN ACUME2 Project
May 13, 2015·Zeitschrift für Gerontologie und Geriatrie·Gan-Zhong WeiWen-Ru Tang
Nov 22, 2011·Journal of Inorganic Biochemistry·Maire E PercyWalter J Lukiw
Sep 7, 2011·Trends in Pharmacological Sciences·Christopher H SwitzerDavid A Wink
Sep 3, 2011·Mechanisms of Ageing and Development·Meryl S LillenesTone Tønjum
Feb 2, 2010·Mechanisms of Ageing and Development·Nicole von Wurmb-SchwarkAlmut Nebel
Nov 10, 2009·Progress in Lipid Research·R TakechiJ C L Mamo
Jun 16, 2009·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Greg M ColeSally A Frautschy
Jun 27, 2009·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Peter B Soeters, Robert F Grimble
Apr 14, 2009·Progress in Lipid Research·S C CunnaneP Barberger-Gateau
Jun 6, 2009·Ageing Research Reviews·Davide SeripaAlberto Pilotto
Jan 1, 2010·Current Gerontology and Geriatrics Research·Makoto SuzukiBradley J Willcox
Aug 20, 2011·NeuroImage·Aaron J TrachtenbergClare E Mackay

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.